SE8702563L - Farmaceutiska kompositioner - Google Patents

Farmaceutiska kompositioner

Info

Publication number
SE8702563L
SE8702563L SE8702563A SE8702563A SE8702563L SE 8702563 L SE8702563 L SE 8702563L SE 8702563 A SE8702563 A SE 8702563A SE 8702563 A SE8702563 A SE 8702563A SE 8702563 L SE8702563 L SE 8702563L
Authority
SE
Sweden
Prior art keywords
pharmaceutical compositions
ketotifen
once
pharmaceutical composition
oral administration
Prior art date
Application number
SE8702563A
Other languages
English (en)
Swedish (sv)
Other versions
SE8702563D0 (sv
Inventor
H Surer
A Riva
Original Assignee
Sandoz Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz Ag filed Critical Sandoz Ag
Publication of SE8702563D0 publication Critical patent/SE8702563D0/xx
Publication of SE8702563L publication Critical patent/SE8702563L/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
SE8702563A 1986-06-21 1987-06-18 Farmaceutiska kompositioner SE8702563L (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE3620830 1986-06-21

Publications (2)

Publication Number Publication Date
SE8702563D0 SE8702563D0 (sv) 1987-06-18
SE8702563L true SE8702563L (sv) 1987-12-22

Family

ID=6303418

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8702563A SE8702563L (sv) 1986-06-21 1987-06-18 Farmaceutiska kompositioner

Country Status (30)

Country Link
US (1) US5399360A (xx)
JP (2) JPS638332A (xx)
KR (1) KR880000095A (xx)
AT (1) AT400521B (xx)
AU (1) AU611637B2 (xx)
BE (1) BE1000661A4 (xx)
CA (1) CA1314227C (xx)
CH (3) CH672735A5 (xx)
CY (1) CY1589A (xx)
DE (1) DE3719818C2 (xx)
DK (1) DK314387A (xx)
ES (1) ES2006170A6 (xx)
FI (1) FI872733A (xx)
FR (1) FR2600253B1 (xx)
GB (1) GB2191696B (xx)
GR (1) GR870965B (xx)
HK (1) HK27691A (xx)
HU (1) HU202753B (xx)
IE (1) IE59178B1 (xx)
IL (1) IL82924A (xx)
IT (1) IT1216822B (xx)
LU (1) LU86928A1 (xx)
MY (1) MY101566A (xx)
NL (1) NL8701335A (xx)
NO (1) NO872551L (xx)
NZ (1) NZ220769A (xx)
PH (1) PH26313A (xx)
PT (1) PT85128B (xx)
SE (1) SE8702563L (xx)
ZA (1) ZA874450B (xx)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5891460A (en) * 1995-06-07 1999-04-06 University Of Southern California University Park Campus Method for reducing or preventing post-surgical adhesion formation using ketotifen and analogs thereof
AU7833698A (en) 1997-06-09 1998-12-30 Bridge Pharma, Inc. Compounds with combined antihistaminic and mast cell stabilizing activities, intended for ophthalmic use
US6740889B1 (en) * 1998-09-28 2004-05-25 Applied Materials, Inc. Charged particle beam microscope with minicolumn
WO2001039774A1 (en) * 1999-12-01 2001-06-07 Klein Pharmaceuticals Topical administration of ketotifen
US20030153620A1 (en) 2000-05-12 2003-08-14 Meakin Timothy David Treating eczema and/or psoriasis
NZ514536A (en) * 2001-09-28 2005-02-25 Meracol Corp Ltd Use of cetyl myristate and/or cetyl palmitate to treat asthma, chronic obstructive pulmonary disease and/or other respiratory difficulties
ITMI20012366A1 (it) * 2001-11-09 2003-05-09 Farmatron Ltd Sistemi terapeutici stabilizzati a rilascio immediato e/o modificato per la somministrazione orale di principi attivi e/o eccipienti e/o ali
JP4867128B2 (ja) * 2002-10-01 2012-02-01 大正製薬株式会社 経口鼻炎治療用組成物
US20060160852A1 (en) * 2004-12-27 2006-07-20 Eisai Co. Ltd. Composition containing anti-dementia drug
US20060159753A1 (en) * 2004-12-27 2006-07-20 Eisai Co. Ltd. Matrix type sustained-release preparation containing basic drug or salt thereof
US20060280789A1 (en) * 2004-12-27 2006-12-14 Eisai Research Institute Sustained release formulations
US20060246003A1 (en) * 2004-12-27 2006-11-02 Eisai Co. Ltd. Composition containing anti-dementia drug
US20070129402A1 (en) * 2004-12-27 2007-06-07 Eisai Research Institute Sustained release formulations
US20090208579A1 (en) * 2004-12-27 2009-08-20 Eisai R & D Management Co., Ltd. Matrix Type Sustained-Release Preparation Containing Basic Drug or Salt Thereof, and Method for Manufacturing the Same
NZ555693A (en) * 2004-12-27 2010-10-29 Eisai R&D Man Co Ltd Matrix type sustained-release preparation containing donepezil
US20100166804A1 (en) * 2007-05-23 2010-07-01 Dennis Penn Methods
WO2009142772A2 (en) 2008-05-23 2009-11-26 Mastcell Pharmaceuticals, Inc. Methods and treatment for allergies and inflammation associated with gastrointestinal diseases
EP2589378A1 (en) * 2010-10-14 2013-05-08 Deva Holding Anonim Sirketi Coating of cetyl myristate and/or cetyl palmitate particles

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH531000A (de) * 1970-03-11 1972-11-30 Sandoz Ag Verfahren zur Herstellung neuer Benzocycloheptathiophene
DE2360796B2 (de) * 1973-12-06 1977-06-02 Edelfettwerke Werner Schlüter, 2000 Hamburg; Glyco Iberica S.A., Gava, Barcelona (Spanien) Vti: Hegel, K.Th., Dr.; Dickel, K., Dipl.-Ing.; Pat.-Anwälte, 2000 Hamburg und 8000 München Arzneimittel mit verzoegerter abgabe des wirkstoffs im darm
DE2426811A1 (de) * 1974-06-04 1976-01-08 Klinge Co Chem Pharm Fab Verfahren zur herstellung von retard-tabletten
JPS51142543A (en) * 1975-05-20 1976-12-08 Sandoz Ag Improvement in organic compound
US4073915A (en) * 1975-05-20 1978-02-14 Sandoz Ltd. Treating asthma
FR2440371A1 (fr) * 1978-10-31 1980-05-30 Fisons Ltd Nouveaux composes azotes heterocycliques, des compositions pharmaceutiques en contenant et des procedes pour les preparer
GB2154874B (en) * 1984-02-29 1987-11-04 Sandoz Ltd Bromoscriptine compositions
KR920010392B1 (ko) * 1984-03-01 1992-11-27 산도즈 아크리엔 게젤샤프트 경피투여용 약학 조성물의 제조방법
DE3421468A1 (de) * 1984-06-08 1985-12-19 Dr. Rentschler Arzneimittel Gmbh & Co, 7958 Laupheim Lipidnanopellets als traegersystem fuer arzneimittel zur peroralen anwendung
NL8502178A (nl) * 1984-08-16 1986-03-17 Sandoz Ag Nieuwe farmaceutische preparaten.
US5069911A (en) * 1985-02-05 1991-12-03 Sandoz Ltd. Pharmaceutical 9,10-dihydrogenated ergot alkaloid containing compositions
DE3505433A1 (de) * 1985-02-16 1986-08-21 Basf Ag, 6700 Ludwigshafen Direkttablettierhilfsmittel
FR2581541B1 (fr) * 1985-05-09 1988-05-20 Rhone Poulenc Sante Nouvelles compositions pharmaceutiques permettant la liberation prolongee d'un principe actif et leur procede de preparation
US4797286A (en) * 1985-11-12 1989-01-10 Eli Lilly And Company Orally administerable sustained release pharmaceutical formulations
US4798725A (en) * 1986-06-16 1989-01-17 Norwich Eaton Pharmaceuticals, Inc. Sustained release capsule

Also Published As

Publication number Publication date
NO872551L (no) 1987-12-22
ES2006170A6 (es) 1989-04-16
HK27691A (en) 1991-04-19
IT8748075A0 (it) 1987-06-19
CY1589A (en) 1992-04-03
NO872551D0 (no) 1987-06-18
FR2600253B1 (fr) 1990-01-26
PH26313A (en) 1992-04-23
FR2600253A1 (fr) 1987-12-24
IE59178B1 (en) 1994-01-26
CH676201A5 (xx) 1990-12-28
BE1000661A4 (fr) 1989-03-07
IL82924A0 (en) 1987-12-20
DK314387A (da) 1987-12-22
CH674805A5 (xx) 1990-07-31
CA1314227C (en) 1993-03-09
KR880000095A (ko) 1988-03-23
JPH05246849A (ja) 1993-09-24
IT1216822B (it) 1990-03-14
FI872733A (fi) 1987-12-22
CH672735A5 (xx) 1989-12-29
IE871634L (en) 1987-12-21
DE3719818C2 (de) 1997-02-13
ATA156187A (de) 1995-06-15
ZA874450B (en) 1989-01-25
SE8702563D0 (sv) 1987-06-18
GR870965B (en) 1987-10-20
AT400521B (de) 1996-01-25
NL8701335A (nl) 1988-01-18
JPS638332A (ja) 1988-01-14
DK314387D0 (da) 1987-06-19
LU86928A1 (fr) 1988-01-20
JP2860013B2 (ja) 1999-02-24
HU202753B (en) 1991-04-29
PT85128A (en) 1987-07-01
US5399360A (en) 1995-03-21
PT85128B (pt) 1990-03-30
FI872733A0 (fi) 1987-06-18
GB8714131D0 (en) 1987-07-22
AU611637B2 (en) 1991-06-20
HUT47428A (en) 1989-03-28
MY101566A (en) 1991-12-17
GB2191696A (en) 1987-12-23
IL82924A (en) 1992-11-15
AU7452587A (en) 1987-12-24
DE3719818A1 (de) 1987-12-23
NZ220769A (en) 1990-12-21
GB2191696B (en) 1991-01-16

Similar Documents

Publication Publication Date Title
SE8702563D0 (sv) Pharmaceutical compositions
DE3874250T2 (de) Anaesthesiemittel enthaltende kaugummi-zusammensetzungen.
IT7949272A0 (it) Composizione per otturazione o ripristino dentario a base di alchilsilossani metacril-sostituiti
DE3868986D1 (de) Pharmazeutische zusammensetzungen.
FI891286A (fi) Hammaskiveä ehkäisevä oraalinen koostumus
FI885122A (fi) Oral komposition innehaollande partiklar som omfattar ett aktivt aemne.
IT8621358A0 (it) Composizione farmaceutica adattivita' analgesica.
DE68901492D1 (de) Orale zusammensetzungen.
IT8721411A0 (it) Composizione farmaceutica idrosolubile contenente n acetilsisteina.
DE68908500D1 (de) Dentalzusammensetzung.
ES2054289T3 (es) Nuevas composiciones a base de imipramina.
AR240014A1 (es) Composicon oral inhibidora de placas dentales.
DE69012702D1 (de) Dentalzusammensetzung.
IT1231012B (it) Composizione farmaceutica per uso orale contenente nac.
IT8721410A0 (it) Composizione farmaceutica idrosolubile contenente n acetilcisteina.
FI872313A (fi) Farmaceutiska kompositioner.
NO890180D0 (no) Munnhygienepreparat.
DE3871083D1 (de) Photopolymerisierbare zusammensetzungen.
DE3877063T2 (de) Photopolymerisierbare dentalzusammensetzung.
MC1878A1 (fr) Compositions pharmaceutiques
IT8722501A0 (it) Formulazioni farmaceutiche per somministrazione transdermica.
IT8621097A1 (it) Derivato di timo attivo per via orale, procedimenti per la sua preparazione e relative composizioni farmaceutiche
DE3866419D1 (de) Photopolymerisierbare dentalzusammensetzung.
IT1216814B (it) Composizioni farmaceutiche
IT8467927A1 (it) Preparati farmaceutici a base di dobutamina somministrabili por via orale.

Legal Events

Date Code Title Description
NAV Patent application has lapsed

Ref document number: 8702563-1

Effective date: 19940101